Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis

被引：111

作者：

Ruiz-Romero, C. ^{[1
]}

Blanco, F. J. ^{[1
]}

机构：

[1] Complejo Hosp Univ A Coruna, Unidad Prote Nodo Asociado ProteoRed Genoma Espan, Ctr Invest Biomed, Lab Invest Osteoarticular & Envejecimiento,Serv R, La Coruna 15006, Spain

来源：

OSTEOARTHRITIS AND CARTILAGE | 2010年 / 18卷 / 04期

关键词：

Osteoarthritis; Cartilage; Proteomics; Biomarkers; Chondrocytes; MATRIX-METALLOPROTEINASE ACTIVITY; RHEUMATOID-ARTHRITIS BIOMARKERS; IMAGING MASS-SPECTROMETRY; SELDI-TOF-MS; SYNOVIAL-FLUID; HUMAN PLASMA; 2-DIMENSIONAL ELECTROPHORESIS; ABSOLUTE QUANTIFICATION; LIQUID-CHROMATOGRAPHY; QUANTITATIVE-ANALYSIS;

D O I：

10.1016/j.joca.2009.11.012

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

100224 [整形外科学];

摘要：

Objective: Osteoarthritis (OA) is the most common rheumatic pathology. It is related to aging and is characterized primarily by cartilage degradation. Despite its high prevalence, the diagnostic methods currently available are limited and lack sensitivity. The focus of this review is the application of proteomic technologies in the search of new biomarkers for improved diagnosis, prognosis and treatment of OA. Methods: This review focuses on the utilization of proteomics in OA biomarker research to enable early diagnosis, improved prognosis and the application of tailored treatments. Results: New diagnostic tests for OA are urgently needed and would also promote the development of alternative therapeutic strategies. Considering that OA involves different tissues and complex biological processes, the most promising diagnostic approach would be the study of combinations of biomarkers. New experimental approaches for the identification and validation of OA biomarkers have recently emerged and include proteomic technologies. These techniques allow the simultaneous analysis of multiple markers and become a very powerful tool for both biomarker discovery and validation. Conclusions: Improvements in proteomics technology will undoubtedly lead to advances in characterizing new OA biomarkers and developing alternative therapies. Even so, further work is required to enhance the performance and reproducibility of proteomics tools before they can be routinely used in clinical trials and practice. (C) 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

引用

页码：500 / 509

页数：10

共 83 条

[1]

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma [J].

Addona, Terri A. ;

Abbatiello, Susan E. ;

Schilling, Birgit ;

Skates, Steven J. ;

Mani, D. R. ;

Bunk, David M. ;

Spiegelman, Clifford H. ;

Zimmerman, Lisa J. ;

Ham, Amy-Joan L. ;

Keshishian, Hasmik ;

Hall, Steven C. ;

Allen, Simon ;

Blackman, Ronald K. ;

Borchers, Christoph H. ;

Buck, Charles ;

Cardasis, Helene L. ;

Cusack, Michael P. ;

Dodder, Nathan G. ;

Gibson, Bradford W. ;

Held, Jason M. ;

Hiltke, Tara ;

Jackson, Angela ;

Johansen, Eric B. ;

Kinsinger, Christopher R. ;

Li, Jing ;

Mesri, Mehdi ;

Neubert, Thomas A. ;

Niles, Richard K. ;

Pulsipher, Trenton C. ;

Ransohoff, David ;

Rodriguez, Henry ;

Rudnick, Paul A. ;

Smith, Derek ;

Tabb, David L. ;

Tegeler, Tony J. ;

Variyath, Asokan M. ;

Vega-Montoto, Lorenzo J. ;

Wahlander, Asa ;

Waldemarson, Sofia ;

Wang, Mu ;

Whiteaker, Jeffrey R. ;

Zhao, Lei ;

Anderson, N. Leigh ;

Fisher, Susan J. ;

Liebler, Daniel C. ;

Paulovich, Amanda G. ;

Regnier, Fred E. ;

Tempst, Paul ;

Carr, Steven A. .

NATURE BIOTECHNOLOGY, 2009, 27 (07) :633-U85

[2]

Mass spectrometry-based proteomics [J].

Aebersold, R ;

Mann, M .

NATURE, 2003, 422 (6928) :198-207

[3]

Aigner T, 2004, METH MOLEC MED, V100, P109

[4]

Functional genomics, evo-devo and systems biology: a chance to overcome complexity? [J].

Aigner, Thomas ;

Haag, Jochen ;

Zimmer, Ralf .

CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (05) :463-470

[5]

Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA) [J].

Anderson, NL ;

Anderson, NG ;

Haines, LR ;

Hardie, DB ;

Olafson, RW ;

Pearson, TW .

JOURNAL OF PROTEOME RESEARCH, 2004, 3 (02) :235-244

[6]

The human plasma proteome - A nonredundant list developed by combination of four separate sources [J].

Anderson, NL ;

Polanski, M ;

Pieper, R ;

Gatlin, T ;

Tirumalai, RS ;

Conrads, TP ;

Veenstra, TD ;

Adkins, JN ;

Pounds, JG ;

Fagan, R ;

Lobley, A .

MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) :311-326

[7]

Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction [J].

Andersson, Malin ;

Groseclose, M. Reid ;

Deutch, Ariel Y. ;

Caprioli, Richard M. .

NATURE METHODS, 2008, 5 (01) :101-108

[8]

Proteomics in clinical trials and practice - Present uses and future promise [J].

Azad, Nilofer S. ;

Rasool, Nabila ;

Annunziata, Christina M. ;

Minasian, Lori ;

Whiteley, Gordon ;

Kohn, Elise C. .

MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) :1819-1829

[9]

Urine proteomics: the present and future of measuring urinary protein components in disease [J].

Barratt, Jonathan ;

Topham, Peter .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 177 (04) :361-368

[10]

Classification of osteoarthritis biomarkers:: a proposed approach [J].

Bauer, D. C. ;

Hunter, D. J. ;

Abramson, S. B. ;

Attur, M. ;

Corr, M. ;

Felson, D. ;

Heinegard, D. ;

Jordan, J. M. ;

Kepler, T. B. ;

Lane, N. E. ;

Saxne, T. ;

Tyree, B. ;

Kraus, V. B. .

OSTEOARTHRITIS AND CARTILAGE, 2006, 14 (08) :723-727

← 1 2 3 4 5 6 7 8 9 →